Publication:
Necrotizing autoimmune myopathy: A case series

Simple item page
dc.contributor.authorSahari N.S.en_US
dc.contributor.authorMarwan A.A.en_US
dc.contributor.authorSuahilai D.M.en_US
dc.contributor.authorJamid N.M.en_US
dc.contributor.authorShahril N.S.en_US
dc.date.accessioned2024-05-29T02:00:50Z
dc.date.available2024-05-29T02:00:50Z
dc.date.issued2020
dc.description.abstractNecrotizing autoimmune myopathy (NAM) is considered a new subgroup of a rare autoimmune idiopathic inflammatory myopathies. Classically, NAM presented with sub-acute onset of proximal muscle loss of power with raised creatinine kinase and characteristic muscle biopsy showing muscle necrosis and regeneration with little inflammation. Statin use, connective tissue diseases, malignancy and HIV infection are the identified risk factors for NAM. The autoantibodies expected to be presented in NAM are anti-signal recognition particle (SRP) and anti-hydroxymethylglutaryl-coenzyme A reductase (anti-HMGCR) antibodies. In this article, we present three cases of NAM with different risk factors and autoantibodies which we believe to have impact on the clinical course and outcome of our patients. � 2020 UPM Press. All rights reserved.
dc.identifier.epage80
dc.identifier.issn16758544
dc.identifier.scopus2-s2.0-85093867098
dc.identifier.spage78
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85093867098&partnerID=40&md5=144919d86bb4e6a86b931374fd810153
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/10139
dc.identifier.volume16
dc.languageEnglish
dc.language.isoen_US
dc.publisherUniversiti Putra Malaysia Pressen_US
dc.relation.ispartofFruits
dc.sourceScopus
dc.subjectAntibodiesen_US
dc.subjectIdiopathic Inflammatory Myopathiesen_US
dc.subjectNecrotizing Autoimmune Myopathyen_US
dc.titleNecrotizing autoimmune myopathy: A case series
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus